DrugPatentWatch Database Preview
Drugs in Development Information for Flupirtine
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
What is the drug development status for Flupirtine?
Flupirtine is an investigational drug.
There have been 4 clinical trials for Flupirtine.
The most recent clinical trial was a Phase 1 trial, which was initiated on December 1st 2007.
The most common disease conditions in clinical trials are Neoplasm Metastasis, Sclerosis, and Multiple Sclerosis, Relapsing-Remitting. The leading clinical trial sponsors are University Medicine Greifswald, AWD.pharma GmbH & Co. KG, and Ludwig-Maximilians - University of Munich.
Summary for Flupirtine
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 1,234 |
| WIPO Patent Applications | 695 |
| Japanese Patent Applications | 4 |
| Clinical Trial Progress | Phase 1 (2007-12-01) |
| Vendors | 36 |
Recent Clinical Trials for Flupirtine
| Title | Sponsor | Phase |
|---|---|---|
| Clinical Studies by Using Accelerated PDX Model to Screen Drugs for Advanced Solid Tumor | Haining Health-Coming Biotech Co., Ltd. | Phase 2 |
| Effect of the Kv7-channel Opener Flupirtine on the Excitability of Human Peripheral Myelinated Axons in Vivo | Ludwig-Maximilians - University of Munich | Phase 1 |
| Pharmacokinetics, Metabolism and Analgesic Effects of Flupirtine | AWD.pharma GmbH & Co. KG | Phase 1 |
Clinical Trial Summary for Flupirtine
Top disease conditions for Flupirtine
Top clinical trial sponsors for Flupirtine
US Patents for Flupirtine
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
